IT & Data Management
IT & Data Management
An Identification Result Doesn’t End at the Report
You are evaluating your identification results for an unknown isolate – what does this organism mean to your manufacturing process, your final product, and the patient? Is it an objectionable, pathogenic organism? Will the correct operational decision be made?...
IT & Data Management
Astrazeneca, Mutabor Are Now Recognised As Allies By OPTIMA
The European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have collaborated on the Innovative Medicines Initiative (IMI), which has announced the commencement of the public-private research programme OPTIMA which is defined as Optimal Treatment for...
IT & Data Management
NPA And Charac Collaborating To Accelerate Digitalization
The National Pharmacy Association (NPA) and Charac, an NHS-integrated one-stop gateway for independent community pharmacists, have established a long-term cooperation to enable pharmacies to provide the wide variety of services required to support the general public.
It comes after Therese...
IT & Data Management
EU Data Transmission On The Accessibility of Human Tissue
The Committee of Ministers for the Council of Europe has recommended that Member States compile information on the usage and supply of tissues and cells so that final users can receive them right away. The Council emphasized in a...
IT & Data Management
Maintain a Greater IDMP Strategy in a Changing Regulatory Landscape
After more than 10 years of preparation, the new Identification of Medicinal Products (IDMP) standard is set to go live in 2023. IDMP facilitates the unique identification of medicinal products in an effort to promote global harmonization of data,...
IT & Data Management
FDA Experts Favor ALS Drug Amylyx, Shifting Former Stance
A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that the agency will approve it in the coming weeks.
The expert group voted 7-2 in favour...
IT & Data Management
Big Data Steering Group To Optimize Data Quality, Visibility
A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA).
The new strategy, according to EMA, will...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
